Condition
Human Immunodeficiency Virus (HIV)
HIV is a virus that attacks the immune system, especially CD4 T cells, though antiretroviral therapy has made it a manageable long-term condition. Research has looked mostly at multivitamin-multimineral formulas, where the evidence is strong, and selenium, where it is moderate, because deficiencies are common in HIV. In one small trial of people whose CD4 counts had responded poorly, adding bovine colostrum to therapy meant CD4 counts went up. Most other findings come from small studies.
Sources: PMID 21930607
- Supplements studied
- 14
- Graded outcomes
- 13
- Trials
- 20
- People studied
- 1,059
Evidence by supplement
- Strong
- Moderate
- Limited
- Very limited
Cannabis
- Analgesic Use: improves
- Ghrelin: improves
- Leptin: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Analgesic Use Small Decrease | Improves (the measure goes down) | Small effect | 4 studies | 34 people | ||
Studies that measured analgesic use
| ||||||
| Ghrelin | Improves (the measure goes up) | 2 studies | 7 people | |||
Studies that measured ghrelin
| ||||||
| Leptin | Improves (the measure goes up) | 1 study | 7 people | |||
Studies that measured leptin | ||||||
| Lymphocyte Count | Improves (the measure goes up) | 1 study | 62 people | |||
Studies that measured lymphocyte count | ||||||
| B Cell Count | Improves (the measure goes up) | 62 people | ||||
| CD4 Lymphocytes | Improves (the measure goes up) | 62 people | ||||
| CD8 Lymphocytes | Improves (the measure goes up) | 62 people | ||||
| Natural Killer Cell Activity | Improves (the measure goes up) | 62 people | ||||
| Natural Killer Cell Content | Improves (the measure goes up) | 62 people | ||||
| Peptide YY (PYY) | Improves (the measure goes up) | 7 people | ||||
Spirulina
- Glycemic Control: improves
- Total Antioxidant Capacity (TAC): improves
- Superoxide Dismutase Activity: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Glycemic Control Small Improvement | Improves (the measure goes up) | Small effect | 1 study | 33 people | ||
Studies that measured glycemic control | ||||||
| Total Antioxidant Capacity (TAC) | Improves (the measure goes up) | 2 studies | 259 people | |||
Studies that measured total antioxidant capacity (tac) | ||||||
| Superoxide Dismutase Activity | Improves (the measure goes up) | 184 people | ||||
Tetradecyl Thioacetic Acid
- Apolipoprotein B: improves
- HbA1c: improves
- Total cholesterol: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Apolipoprotein B Small Improvement | Improves (the measure goes down) | Small effect | 10 people | |||
| HbA1c | Improves (the measure goes down) | 1 study | 10 people | |||
| Total cholesterol | Improves (the measure goes down) | 1 study | 10 people | |||
Studies that measured total cholesterol | ||||||
| Weight | Improves (the measure goes down) | 1 study | 10 people | |||
| Glycemic Control | Improves (the measure goes up) | 10 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 10 people | ||||
| HIV Viral Load | Improves (the measure goes up) | 10 people | ||||
| Kidney Function | Improves (the measure goes up) | 10 people | ||||
| Liver Enzymes | Changes; see studies | 10 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 10 people | ||||
| TNF-Alpha | Improves (the measure goes down) | 10 people | ||||
| Triglycerides | Improves (the measure goes down) | 10 people | ||||
Policosanol
- High-density lipoprotein (HDL): improves
- Low-density lipoprotein (LDL): improves
- Total cholesterol: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| High-density lipoprotein (HDL) Small Improvement | Improves (the measure goes up) | Small effect | 54 people | |||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 10 studies | 54 people | |||
Studies that measured low-density lipoprotein (ldl) | ||||||
| Total cholesterol | Improves (the measure goes down) | 3 studies | 54 people | |||
Studies that measured total cholesterol
| ||||||
Fish Oil
- C-Reactive Protein (CRP)
- Triglycerides: improves
- High-density lipoprotein (HDL): improves
DHEA
- Bone Mineral Density
- Muscle Mass: improves
- Subjective Well-Being: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Bone Mineral Density No effect | NoneNo effect | 2 studies | 40 people | |||
Studies that measured bone mineral density | ||||||
| Muscle Mass | Improves (the measure goes up) | 2 studies | 40 people | |||
| Subjective Well-Being | Improves (the measure goes up) | 1 study | 40 people | |||
Studies that measured subjective well-being | ||||||
King of Bitters
- CD4 Lymphocytes
- Early Virologic Response: improves
- Liver Enzymes: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| CD4 Lymphocytes No effect | NoneNo effect | 1 study | 34 people | |||
Studies that measured cd4 lymphocytes | ||||||
| Early Virologic Response | Improves (the measure goes up) | 17 people | ||||
| Liver Enzymes | Changes; see studies | 17 people | ||||
Guduchi
- CD4 Lymphocytes
- Eosinophil count: changes; see studies
- HIV Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| CD4 Lymphocytes No effect | NoneNo effect | 68 people | ||||
| Eosinophil count | Changes; see studies | 68 people | ||||
| HIV Symptoms | Improves (the measure goes down) | 68 people | ||||
| Neutrophil Count | Improves (the measure goes up) | 68 people | ||||
| T Cell Count | Improves (the measure goes up) | 68 people |
Alanylglutamine
- CD4 Lymphocytes
- HIV Viral Load: improves
- Intestinal Permeability: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| CD4 Lymphocytes No effect | NoneNo effect | 37 people | ||||
| HIV Viral Load | Improves (the measure goes up) | 1 study | 37 people | |||
Studies that measured hiv viral load | ||||||
| Intestinal Permeability | Improves (the measure goes up) | 37 people | ||||
| Weight | Changes; see studies | 37 people | ||||
Guduchi
- CD4 Lymphocytes
- HIV Symptoms: improves
- Eosinophil count: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| CD4 Lymphocytes No effect | NoneNo effect | 68 people | ||||
| HIV Symptoms | Improves (the measure goes down) | 1 study | 68 people | |||
Studies that measured hiv symptoms | ||||||
| Eosinophil count | Changes; see studies | 68 people | ||||
| Neutrophil Count | Improves (the measure goes up) | 68 people | ||||
| T Cell Count | Improves (the measure goes up) | 68 people | ||||
Lactobacillus reuteri
- Bilirubin
- Blood Pressure: improves
- Heart Rate: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Bilirubin No effect | NoneNo effect | 39 people | ||||
| Blood Pressure | Improves (the measure goes down) | 1 study | 39 people | |||
| Heart Rate | Improves (the measure goes down) | 1 study | 39 people | |||
| Triglycerides | Improves (the measure goes down) | 1 study | 39 people | |||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 39 people | ||||
| Kidney Function | Improves (the measure goes up) | 39 people | ||||
| Liver Enzymes | Changes; see studies | 39 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 39 people | ||||
| Lymphocyte Count | Improves (the measure goes up) | 39 people | ||||
| Monocyte Count | Improves (the measure goes up) | 39 people | ||||
| Neutrophil Count | Improves (the measure goes up) | 39 people | ||||
| Red Blood Cell Count | Improves (the measure goes up) | 39 people | ||||
| Serum Platelets | Improves (the measure goes up) | 39 people | ||||
| Total cholesterol | Improves (the measure goes down) | 39 people | ||||
| Weight | Improves (the measure goes down) | 39 people | ||||
| White Blood Cell Count | Improves (the measure goes up) | 39 people |
Alpha-Lipoic Acid
- Oxidative Stress Biomarkers: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Oxidative Stress Biomarkers | Changes; see studies | 4 studies | 33 people |
Key findings
- CD4 LymphocytesImproves (the measure goes up)
- Blood glucoseImproves (the measure goes down)
- Analgesic UseImproves (the measure goes down)
The HIV/AIDS Nutritional Support protocol
2 primary supplements · 5 supporting supplements
- Multivitamin/MultimineralHigh-potency multivitamin daily
- Selenium200 mcg daily
Studies cited
100 studies from PubMed
- Effects of spirulina and wakame consumption on intestinal cholesterol absorption and serum lipid concentrations in non-hypercholesterolemic adult men and women
- Chromium in PCOS: A Systematic Review and Meta-Analysis
- Spirulina in Health and Disease Prevention: A Comprehensive Review
- Chromium Supplementation and Metabolic Diseases: Evidence from Clinical Trials
- Effects of Chromium Supplementation on Body Composition: A Systematic Review
- Safety of Chromium Supplementation: Evidence from Clinical Studies
- Spirulina Supplementation and Metabolic Syndrome: A Meta-Analysis
- Spirulina and Allergic Rhinitis: A Systematic Review
- Spirulina (Arthrospira): Nutritional Value and Health Effects
- Spirulina and Immune Function: A Systematic Review
- Safety Assessment of Spirulina (Arthrospira) as a Dietary Supplement
- Effects of Chromium Supplementation on Glucose Metabolism and Lipids: A Systematic Review and Meta-Analysis
- Chromium and Insulin Sensitivity: A Review of Mechanisms
- Chromium Supplementation in Depression and Mood Disorders: A Review
- Chromium Supplementation and Glycemic Control in Diabetes: An Updated Review
- A Systematic Review of the Effects of Spirulina on Cardiovascular Risk Factors
- Effects of Spirulina on Lipid Profile: A Systematic Review and Meta-Analysis
- Chromium Picolinate in Type 2 Diabetes: A Meta-Analysis of Randomized Trials
- Chromium Effects on Blood Pressure: A Meta-Analysis
- Antioxidant and Anti-Inflammatory Effects of Spirulina: Evidence from Clinical Studies
- Effects of Spirulina on Body Weight and Blood Glucose: A Meta-Analysis
- Effect of Spirulina maxima on postprandial lipemia in young runners: a preliminary report
- Wheat grass supplementation decreases oxidative stress in healthy subjects: a comparative study with spirulina
- Effects of acute chromium supplementation on postprandial metabolism in healthy young men
- The effects of inorganic chromium and brewer's yeast on glucose tolerance, plasma lipids, and plasma chromium in elderly subjects
- Effects of resistance training and chromium picolinate on body composition and skeletal muscle in older men
- Effects of bovine colostrum supplementation on immune variables in highly trained cyclists
- IGF-I, IgA, and IgG responses to bovine colostrum supplementation during training
- Effects of bovine colostrum supplementation on serum IGF-I, IgG, hormone, and saliva IgA during training
- Improvement of intestinal permeability with alanyl-glutamine in HIV patients: a randomized, double blinded, placebo-controlled clinical trial
- Examination of the efficacy of acute L-alanyl-L-glutamine ingestion during hydration stress in endurance exercise
- L-alanyl-L-glutamine ingestion maintains performance during a competitive basketball game
- L-glutamine absorption is enhanced after ingestion of L-alanylglutamine compared with the free amino acid or wheat protein
- Effects of alpha-lipoic acid supplementation in peripheral arterial disease: a pilot study
- Down syndrome and dementia: a randomized, controlled trial of antioxidant supplementation
- Effects of antioxidant supplements intervention on the level of plasma inflammatory molecules and disease severity of rheumatoid arthritis patients
- Effect of α-lipoic acid and exercise training on cardiovascular disease risk in obesity with impaired glucose tolerance
- Alpha-lipoic acid supplementation: a tool for obesity therapy?
- Effects of alpha-lipoic Acid on body weight in obese subjects
- Oral antioxidant supplementation does not prevent acute mountain sickness: double blind, randomized placebo-controlled trial
- A preliminary evaluation of a novel method to monitor a triple antioxidant combination (vitamins E, C and α-lipoic acid) in diabetic volunteers using in vitro methaemoglobin formation
- Glycemic and oxidative status of patients with type 2 diabetes mellitus following oral administration of alpha-lipoic acid: a randomized double-blinded placebo-controlled study
- Complementary therapy in diabetic patients with chronic complications: a pilot study
- The effects of lipoic acid and α-tocopherol supplementation on the lipid profile and insulin sensitivity of patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial
- Alpha-lipoic acid does not acutely affect resistance and conduit artery function or oxidative stress in healthy men
- Effects of Alpha-Lipoic Acid Supplementation on Inflammation, Oxidative Stress, and Serum Lipid Profile Levels in Patients with End-Stage Renal Disease on Hemodialysis
- Alpha-lipoic acid improves endothelial dysfunction in patients with subclinical hypothyroidism
- Irbesartan and lipoic acid improve endothelial function and reduce markers of inflammation in the metabolic syndrome: results of the Irbesartan and Lipoic Acid in Endothelial Dysfunction (ISLAND) study
- Oral antioxidants and cardiovascular health in the exercise-trained and untrained elderly: a radically different outcome
- Effects of supplementation with alpha-lipoic acid on exercise-induced activation of coagulation
- Efficacy and safety of antioxidant treatment with α-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial
- Alpha-lipoic acid improves vascular endothelial function in patients with type 2 diabetes: a placebo-controlled randomized trial
- Effect of alpha-lipoic acid combined with creatine monohydrate on human skeletal muscle creatine and phosphagen concentration
- Alpha-lipoic acid modifies oxidative stress parameters in sickle cell trait subjects and sickle cell patients
- The use of alpha-lipoic acid (ALA), gamma linolenic acid (GLA) and rehabilitation in the treatment of back pain: effect on health-related quality of life
- Assessment of the antioxidant effectiveness of alpha-lipoic acid in healthy men exposed to muscle-damaging exercise
- Restoration of blood total glutathione status and lymphocyte function following alpha-lipoic acid supplementation in patients with HIV infection
- Efficacy of Alpha Lipoic Acid Supplementation in Sperm Parameters: A Systematic Review and Meta-Analysis of Randomized Trials.
- Effects of oral, smoked, and vaporized cannabis on endocrine pathways related to appetite and metabolism: a randomized, double-blind, placebo-controlled, human laboratory study
- 1 -tetrahydrocannabinol, synhexyl and marijuana extract administered orally in man: catecholamine excretion, plasma cortisol levels and platelet serotonin content
- Acute effects of natural and synthetic cannabis compounds on prolactin levels in human males
- The effects of smoked marijuana on metabolism and respiratory control
- Effect of acute Δ9-tetrahydrocannabinol administration on subjective and metabolic hormone responses to food stimuli and food intake in healthy humans: a randomized, placebo-controlled study
- Explorative Placebo-Controlled Double-Blind Intervention Study with Low Doses of Inhaled Δ9-Tetrahydrocannabinol and Cannabidiol Reveals No Effect on Sweet Taste Intensity Perception and Liking in Humans
- Short-term effects of cannabinoids on immune phenotype and function in HIV-1-infected patients
- A pilot study of the effects of cannabis on appetite hormones in HIV-infected adult men
- Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial
- Acute and residual mood and cognitive performance of young adults following smoked cannabis
- Effects of acute marijuana smoking on pulse rate and mood states in women
- Assessment of Efficacy and Tolerability of Medicinal Cannabinoids in Patients With Multiple Sclerosis: A Systematic Review and Meta-analysis
- Sativex ® as add-on therapy vs. further optimized first-line ANTispastics (SAVANT) in resistant multiple sclerosis spasticity: a double-blind, placebo-controlled randomised clinical trial
- Sativex(®) and clinical-neurophysiological measures of spasticity in progressive multiple sclerosis
- Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up
- Multiple sclerosis and extract of cannabis: results of the MUSEC trial
- A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis
- Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients
- Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis
- Psychopathological and cognitive effects of therapeutic cannabinoids in multiple sclerosis: a double-blind, placebo controlled, crossover study
- A placebo-controlled, parallel-group, randomized withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex® (nabiximols)
- Sativex long-term use: an open-label trial in patients with spasticity due to multiple sclerosis
- Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial
- A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis
- A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis
- Tetrahydrocannabinol and cannabidiol oromucosal spray in resistant multiple sclerosis spasticity: consistency of response across subgroups from the SAVANT randomized clinical trial
- Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis
- Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled, crossover study
- Short-term effects of smoking marijuana on balance in patients with multiple sclerosis and normal volunteers
- The effect of cannabis on urge incontinence in patients with multiple sclerosis: a multicentre, randomised placebo-controlled trial (CAMS-LUTS)
- Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis
- Smoked marijuana effects on tobacco cigarette smoking behavior
- Abstinence symptoms following smoked marijuana in humans
- Abstinence symptoms following oral THC administration to humans
- Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition
- Acute and residual effects of smoked cannabis: Impact on driving speed and lateral control, heart rate, and self-reported drug effects
- Effect of cannabis use on cognitive functions and driving ability
- Cannabis smoking impairs driving performance on the simulator and real driving: a randomized, double-blind, placebo-controlled, crossover trial
- Acute effects of smoking marijuana on hormones, subjective effects and performance in male human subjects
- The effects of orally administered delta 9-tetrahydrocannabinol in man on mood and performance measures: a dose-response study
- Opioid antagonism enhances marijuana's effects in heavy marijuana smokers
- Cannabis use and driving-related performance in young recreational users: a within-subject randomized clinical trial